Inventor · disambiguated record
Maxim Egorov
Also filed as: EGOROV MAXIM · EGOROV MAXIM V · EGOROV MAXIM VIKTOROVICH
8 granted patents·3 pending applications·8 citations·filing 2009–2022
78Inventor score
Top patents by PatentIndex Score
11 records- 0169US9192676B2Oral formulations of mitochondrially-targeted antioxidants and their preparation and useSKULACHEV MAXIM V·Filed 2012·Granted Nov 24, 2015·3 cites·19 claims
- 0260US8361993B2Hydroxy-bisphosphonic acid derivatives as vector targeting bone tissueUNIV NANTES·Filed 2009·Granted Jan 29, 2013·1 cites·14 claims
- 0358US9744180B2Pharmaceutical formulations containing mitochondrially targeted antioxidantsMITOTECH SA·Filed 2014·Granted Aug 29, 2017·1 cites·8 claims
- 0456US9173946B2Bifunctional hydroxy-bisphosphonic acid derivativesEGOROV MAXIM·Filed 2012·Granted Nov 3, 2015·2 cites·19 claims
- 0555US10188669B2Mitochondria-targeted antioxidants for treatment of age-related brain disordersMITOTECH S A·Filed 2016·Granted Jan 29, 2019·1 cites·15 claims
- 0642US9546159B2N-substituted 3,4-bis (catechol) pyrrole compounds, and the preparation and use thereof in the treatment of cancerCENTRE NAT DE LA RECH SCIENT (CNRS)·Filed 2013·Granted Jan 17, 2017·0 cites·19 claims
- 0742US2023181604A1Use of Mitochondria-Targeted Antioxidants to Treat Severe Inflammatory ConditionsMITOTECH S A·Filed 2021·Application pending·0 cites
- 0841US2025281620A1Hydroxybisphosphonic derivatives of meloxicam for the treatment of inflammatory joint diseasesATLANTHERA·Filed 2022·Application pending·0 cites
- 0937US9572890B2Oral formulations of mitochondrially-targeted antioxidants and their preparation and useMITOTECH SA·Filed 2015·Granted Feb 21, 2017·0 cites·9 claims
- 1032US2014329776A1Mitochondria-Targeted Antioxidants for Treatment of Age-Related Brain DisordersMITOTECH S A·Filed 2012·Application pending·0 cites
- 1118US10238671B2Hydrosoluble hydroxybisphosphonic derivatives of doxorubicinATLANTHERA·Filed 2015·Granted Mar 26, 2019·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Maxim Egorov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →